<?xml version="1.0" encoding="UTF-8"?>
<document id="30270440">
	<sentence id="s1" text="The negative regulation of transcription by RNA polymerase II of superoxide metabolic process and regulation of cell growth on cancer development is only partly explored.">
		<entity id="s1.e1" charOffset="4-61"
			type="GO" text="negative regulation of transcription by RNA polymerase II" ontology_id="GO_0000122"/>
		<entity id="s1.e2" charOffset="14-42"
			type="GO" text="superoxide metabolic process" ontology_id="GO_0006801"/>
		<entity id="s1.e3" charOffset="47-72"
			type="GO" text="regulation of cell growth" ontology_id="GO_0001558"/>
		<entity id="s1.e4" charOffset="54-60"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s1.p1" e1="s1.e4"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p2" e1="s1.e3"
		    e2="s1.e4" pgr="false"/>
		<pair id="s1.p3" e1="s1.e1"
		    e2="s1.e4" pgr="false"/>
	</sentence>
	<sentence id="s2" text="Recent research published in the Journal of Pathology showed that genetic depletion of any of the superoxide metabolic process subunits cytochrome complex assembly, superoxide metabolic process, protein targeting to membrane, antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent and superoxide metabolic process reduced the formation of lung metastases following intravenous injection of murine tumor cells.">
		<entity id="s2.e1" charOffset="98-126"
			type="GO" text="superoxide metabolic process" ontology_id="GO_0006801"/>
		<entity id="s2.e2" charOffset="136-163"
			type="GO" text="cytochrome complex assembly" ontology_id="GO_0017004"/>
		<entity id="s2.e3" charOffset="165-193"
			type="GO" text="superoxide metabolic process" ontology_id="GO_0006801"/>
		<entity id="s2.e4" charOffset="195-224"
			type="GO" text="protein targeting to membrane" ontology_id="GO_0006612"/>
		<entity id="s2.e5" charOffset="226-321"
			type="GO" text="antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent" ontology_id="GO_0002479"/>
		<entity id="s2.e6" charOffset="251-256"
			type="HP" text="tumor" ontology_id="HP_0002664"/>
		<entity id="s2.e7" charOffset="326-354"
			type="GO" text="superoxide metabolic process" ontology_id="GO_0006801"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e6" pgr="false"/>
		<pair id="s2.p2" e1="s2.e2"
		    e2="s2.e6" pgr="false"/>
		<pair id="s2.p3" e1="s2.e3"
		    e2="s2.e6" pgr="false"/>
		<pair id="s2.p4" e1="s2.e4"
		    e2="s2.e6" pgr="false"/>
		<pair id="s2.p5" e1="s2.e5"
		    e2="s2.e6" pgr="false"/>
		<pair id="s2.p6" e1="s2.e7"
		    e2="s2.e6" pgr="false"/>
	</sentence>
	<sentence id="s3" text="These findings, together with the role of superoxide metabolic process in maintaining self-tolerance, imply that NOX2 is a targetable immune checkpoint in cancer.">
		<entity id="s3.e1" charOffset="42-70"
			type="GO" text="superoxide metabolic process" ontology_id="GO_0006801"/>
		<entity id="s3.e2" charOffset="155-161"
			type="HP" text="cancer" ontology_id="HP_0002664"/>
		<pair id="s3.p1" e1="s3.e1"
		    e2="s3.e2" pgr="false"/>
	</sentence>
</document>
